Status:

COMPLETED

Screening Evaluation for Studies of Chronic Obstructive Pulmonary Disease (COPD)

Lead Sponsor:

Johns Hopkins University

Collaborating Sponsors:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Chronic Obstructive Pulmonary Disease

Eligibility:

All Genders

40-100 years

Brief Summary

This research is being done to study mechanisms of progression of COPD and to develop treatments for it. The investigators are doing the present study to identify people age 40 and older with mild to ...

Detailed Description

This is a program to recruit and screen participants for clinical trials or more detailed observational studies of COPD. There are no interventions or comparative results to be published from this stu...

Eligibility Criteria

Inclusion

  • Age 40 years and older, either sex
  • Mild to moderate COPD (FEV1/Forced vital capacity (FVC) ratio ≤ 0.70, FEV1 30-70% predicted, Diffusing capacity of the lungs for carbon monoxide (DLCO) ≥35% predicted)
  • On stable maintenance therapy for 2 months
  • Current or former smoker (patient report of at least a 10 pack-year history)
  • Ability to understand and willingness to sign consent documents

Exclusion

  • COPD exacerbation requiring treatment within past 6 weeks
  • Untreated arterial hypertension (systolic blood pressure \> 140 mm Hg, diastolic blood pressure \> 90 mm Hg)
  • Decompensated heart failure
  • Myocardial infarction within past 3 months or ever
  • Evidence of interstitial, occupational or chronic infectious lung disease
  • Renal dysfunction
  • Supplemental oxygen \> 2 liters/m at rest
  • Failure to keep screening appointments

Key Trial Info

Start Date :

January 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 1 2017

Estimated Enrollment :

670 Patients enrolled

Trial Details

Trial ID

NCT00889447

Start Date

January 1 2008

End Date

May 1 2017

Last Update

March 12 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Johns Hopkins Asthma and Allergy Center

Baltimore, Maryland, United States, 21224

Screening Evaluation for Studies of Chronic Obstructive Pulmonary Disease (COPD) | DecenTrialz